Construction and identification of an RNA interference lentiviral vector targeting the mouse TNF-α gene

Wang,Jibo; Liang,Hongda; Zhao,Yingjie; Liu,Xiangping; Yang,Kun; Sui,Aihua

doi:10.3892/etm.2015.2813

Construction and identification of an RNA interference lentiviral vector targeting the mouse TNF-α gene

Authors:
- Jibo Wang
- Hongda Liang
- Yingjie Zhao
- Xiangping Liu
- Kun Yang
- Aihua Sui
View Affiliations

Affiliations: Department of Rheumatology and Clinical Immunology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China, Department of Central Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, P.R. China
Published online on: October 19, 2015 https://doi.org/10.3892/etm.2015.2813
Pages: 2283-2288

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to construct RNA interference (RNAi) lentiviral vector particles targeting the mouse tumor necrosis factor-α (TNF-α) gene. Three types of small interfering RNA (siRNA) targeting the mouse TNF-α gene were designed, synthesized and transfected into RAW264.7 cells. Screening was performed to identify the siRNA sequence exhibiting the highest inhibition efficiency; based on this, recombinant lentiviral plasmids were constructed and co‑transfected into 293T cells with packaging plasmids for the production of lentiviral particles. The screening results showed that the TNF‑α mRNA expression levels of the three siRNA groups were significantly lower than those of the negative control group, with the highest inhibition rate in the siRNA2 group (83.09%). Similarly, the expression levels of TNF‑α protein in the three siRNA groups were significantly lower than those of the negative control group, and the highest inhibition rate was found in the siRNA2 group (51.16%). The mRNA expression of interleukin (IL)‑1β and IL‑6 showed no significant difference among the siRNA groups and the negative control. The recombinant lentiviral shuttle plasmid was constructed, and electrophoresis revealed the polymerase chain reaction product to be 343 bp, while that of the empty vector was 306 bp; DNA sequencing showed partial insertion. The virus titer was calculated to be 2x106 TU/µl. In conclusion, RNAi lentiviral vector particles targeting the mouse TNF‑α gene were successfully obtained in the present study. This method may be used to produce lentiviral vector for the in vivo study of RNAi gene therapy targeting TNF-α.

View Figures

View References

1	Chen SY, Shiau AL, Li YT, Lin YS, Lee CH, Wu CL and Wang CR: Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of Toll-like receptor 7 short hairpin RNA gene. Gene Ther. 19:752–760. 2012. View Article : Google Scholar : PubMed/NCBI
2	Sakuma T, Barry MA and Ikeda Y: Lentiviral vectors: Basic to translational. Biochem J. 443:603–618. 2012. View Article : Google Scholar : PubMed/NCBI
3	Gouze E, Pawliuk R, Pilapil C, Gouze JN, Fleet C, Palmer GD, Evans CH, Leboulch P and Ghivizzani SC: In vivo gene delivery to synovium by lentiviral vectors. Mol Ther. 5:397–404. 2002. View Article : Google Scholar : PubMed/NCBI
4	Lewis PF and Emerman M: Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol. 68:510–516. 1994.PubMed/NCBI
5	Naldini L, Blömer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM and Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 272:263–267. 1996. View Article : Google Scholar : PubMed/NCBI
6	Wilson AA, Kwok LW, Porter EL, Payne JG, McElroy GS, Ohle SJ, Greenhill SR, Blahna MT, Yamamoto K, Jean JC, et al: Lentiviral delivery of RNAi for in vivo lineage-specific modulation of gene expression in mouse lung macrophages. Mol Ther. 21:825–833. 2013. View Article : Google Scholar : PubMed/NCBI
7	Wollebo HS, Woldemichaele B and White MK: Lentiviral transduction of neuronal cells. Methods Mol Biol. 1078:141–146. 2013. View Article : Google Scholar : PubMed/NCBI
8	Houbracken I, Baeyens L, Ravassard P, Heimberg H and Bouwens L: Gene delivery to pancreatic exocrine cells in vivo and in vitro. BMC Biotechnol. 12:742012. View Article : Google Scholar : PubMed/NCBI
9	Moelants EA, Mortier A, Van Damme J and Proost P: Regulation of TNF-α with a focus on rheumatoid arthritis. Immunol Cell Biol. 91:393–401. 2013. View Article : Google Scholar : PubMed/NCBI
10	Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI
11	Svoboda P: Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther. 9:248–257. 2007.PubMed/NCBI
12	Lin X, Yu Y, Zhao H, Zhang Y, Manela J and Tonetti DA: Overexpression of PKCalpha is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model. Carcinogenesis. 27:1538–1546. 2006. View Article : Google Scholar : PubMed/NCBI
13	Qiu Z, Huang C, Sun J, Qiu W, Zhang J, Li H, Jiang T, Huang K and Cao J: RNA interference-mediated signal transducers and activators of transcription 3 gene silencing inhibits invasion and metastasis of human pancreatic cancer cells. Cancer Sci. 98:1099–1106. 2007. View Article : Google Scholar : PubMed/NCBI
14	Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y and Feng Y: Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Cancer. 107:746–756. 2006. View Article : Google Scholar : PubMed/NCBI
15	Khoury M, Louis-Plence P, Escriou V, Noel D, Largeau C, Cantos C, Scherman D, Jorgensen C and Apparailly F: Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. Arthritis Rheum. 54:1867–1877. 2006. View Article : Google Scholar : PubMed/NCBI
16	Zhu ZG, Jin H, Yu PJ, Tian YX, Zhang JJ and Wu SG: Mollugin inhibits the inflammatory response in lipopolysaccharide-stimulated RAW264.7 macrophages by blocking the Janus kinase-signal transducers and activators of transcription signaling pathway. Biol Pharm Bull. 36:399–406. 2013. View Article : Google Scholar : PubMed/NCBI
17	Qureshi AA, Guan XQ, Reis JC, Papasian CJ, Jabre S, Morrison DC and Qureshi N: Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis. 11:762012. View Article : Google Scholar : PubMed/NCBI
18	Kusumawati A, Commes T, Liautard JP and Widada JS: Transfection of myelomonocytic cell lines: Cellular response to a lipid-based reagent and electroporation. Anal Biochem. 269:219–221. 1999. View Article : Google Scholar : PubMed/NCBI
19	Liao HS, Kodama T, Doi T, Emi M, Asaoka H, Itakura H and Matsumoto A: Novel elements located at −504 to −399 bp of the promoter region regulated the expression of the human macrophage scavenger receptor gene in murine macrophages. J Lipid Res. 38:1433–1444. 1997.PubMed/NCBI
20	Wirtz S, Becker C, Blumberg R, Galle PR and Neurath MF: Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J Immunol. 168:411–420. 2002. View Article : Google Scholar : PubMed/NCBI
21	Lee JS, Hmama Z, Mui A and Reiner NE: Stable gene silencing in human monocytic cell lines using lentiviral-delivered small interference RNA. Silencing of the p110alpha isoform of phosphoinositide 3-kinase reveals differential regulation of adherence induced by 1alpha,25-dihydroxycholecalciferol and bacterial lipopolysaccharide. J Biol Chem. 279:9379–9388. 2004. View Article : Google Scholar : PubMed/NCBI
22	Guo Y, Liu J, Li YH, Song TB, Wu J, Zheng CX and Xue CF: Effect of vector-expressed shRNAs on hTERT expression. World J Gastroenterol. 11:2912–2915. 2005. View Article : Google Scholar : PubMed/NCBI
23	McIntyre GJ and Fanning GC: Design and cloning strategies for constructing shRNA expression vectors. BMC Biotechnol. 6:12006. View Article : Google Scholar : PubMed/NCBI